Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 2/20 | 0.34 |
| ▸ | CTSB | P07858 | 2/20 | 0.34 |
| ▸ | CTSH | P09668 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 4/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | KLK7 | P49862 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2059847 | 0.85 | SLC1A3 (0.42) | TSHRCTSLCTSBCTSHCTSK | |
| SCHEMBL17471357 | 0.84 | SMN1; SMN2 (0.38) | SMN1; SMN2CTSLCTSBCTSHCTSK | |
| SCHEMBL631546 | 0.79 | SMN1; SMN2 (0.35) | SMN1; SMN2TSHRCTSLCTSBCTSH | |
| SCHEMBL3267819 | 0.79 | TSHR (0.47) | TSHR | |
| SCHEMBL9963788 | 0.79 | KMT2A (0.39) | SMN1; SMN2 | |
| SCHEMBL16874410 | 0.78 | THRB (0.46) | SMN1; SMN2TSHREPHX1 | |
| SCHEMBL22567313 | 0.78 | THRB (0.46) | SMN1; SMN2TSHREPHX1 | |
| SCHEMBL1394651 | 0.78 | THRB (0.46) | SMN1; SMN2TSHREPHX1 | |
| SCHEMBL16591159 | 0.77 | SMN1; SMN2 (0.38) | SMN1; SMN2CTSLCTSBCTSHCTSK | |
| SCHEMBL12431464 | 0.76 | TSHR (0.39) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3253735-B1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2021-03-31 | — | — | EP | disclosed |
| US-9994538-B2 | Latent acids and their use | BASF SE (DE) | 2018-06-12 | — | — | US | disclosed |
| US-9964848-B2 | Positive photosensitive resin composition and cured film forming method using the same | FUJIFILM CORPORATION (JP) | 2018-05-08 | — | — | US | disclosed |
| US-20180009775-A1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2018-01-11 | — | — | US | disclosed |
| EP-2420890-B1 | Positive photosensitive resin composition, method for forming cured film and liquid crystal display device | FUJIFILM CORP (JP) | 2017-03-01 | — | — | EP | disclosed |
| EP-2613198-B1 | PHOTOSENSITIVE RESIN COMPOSITION, OXIME SULFONATE COMPOUND, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORP (JP) | 2016-12-28 | — | — | EP | disclosed |
| WO-2016124493-A1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2016-08-11 | — | — | WO | disclosed |
| US-20150212406-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND CURED FILM FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2015-07-30 | — | — | US | disclosed |
| US-9034440-B2 | Positive photosensitive resin composition and cured film forming method using the same | FUJIFILM CORPORATION (JP) | 2015-05-19 | — | — | US | disclosed |
| US-8932800-B2 | Positive photosensitive resin composition and method for forming cured film using the same | FUJIFILM CORPORATION (JP) | 2015-01-13 | — | — | US | disclosed |
| US-20110177302-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD OF FORMING CURED FILM FROM THE SAME | FUJIFILM CORPORATION (JP) | 2011-07-21 | — | — | US | disclosed |
| CN-102043333-A | Photosensitive resin composition, method for producing cured film, cured film, organic el display device and liquid crystal display device | FUJIFILM CORP | 2011-05-04 | — | — | CN | disclosed |
| CN-102043334-A | Photosensitive resin composition, cured film, method for producing cured film, organic el display device and liquid crystal display device | FUJIFILM CORP | 2011-05-04 | — | — | CN | disclosed |
| CN-102043335-A | Photosensitive resin composition, cured film, method for producing cured film, organic el display device and liquid crystal display device | FUJIFILM CORP | 2011-05-04 | — | — | CN | disclosed |
| EP-2261737-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD OF FORMING CURED FILM FROM THE SAME | FUJIFILM Corporation (JP) | 2010-12-15 | — | — | EP | disclosed |
| CN-101809503-A | Positive-type photosensitive resin composition, and method for formation of cured film using the same | FUJIFILM CORP | 2010-08-18 | — | — | CN | disclosed |
| US-20100173246-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING CURED FILM USING THE SAME | FUJIFILM CORPORATION (JP) | 2010-07-08 | — | — | US | disclosed |
| EP-2196852-A1 | POSITIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION, AND METHOD FOR FORMATION OF CURED FILM USING THE SAME | Fujifilm Corporation (JP) | 2010-06-16 | — | — | EP | disclosed |
| CN-101681110-A | Positive photosensitive resin composition and method for forming cured film using the same | SATOSHI TAKITA | 2010-03-24 | — | — | CN | disclosed |
| EP-2154571-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD OF FORMING CURED FILM THEREFROM | Fujifilm Corporation (JP) | 2010-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180009775-A1 | LATENT ACIDS AND THEIR USE | LTA, C1S, C9 | SMN1; SMN2 4885/4885TSHR 3529/4885CTSL 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.